Landfar Bio medicine Co

Landfar Bio medicine Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Landfar Bio medicine Co (000504.SZ) as of Oct 11, 2026 is 30.86 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -12.32 M CNY — a change of -350.42% (higher).

EBITDA

30.86 MCNY

YoY

-350.42%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Landfar Bio medicine Co is 2025 30.86 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Landfar Bio medicine Co was 2024 -12.32 M CNY. It decreases by -350.42% higher compared to the previous year.

The Landfar Bio medicine Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-19.70 M CNY
Jan 1, 2019
31.72 M CNY
Jan 1, 2020
24.84 M CNY
Jan 1, 2021
-24.64 M CNY
Jan 1, 2022
-20.49 M CNY
Jan 1, 2023
-39.11 M CNY
Jan 1, 2024
-12.32 M CNY
Jan 1, 2025
30.86 M CNY
The Landfar Bio medicine Co EBITDA history
YEAREBITDAYoY
30.86 MCNY-350.42%
-12.32 MCNY-68.49%
-39.11 MCNY+90.85%
-20.49 MCNY-16.82%
-24.64 MCNY-199.19%
24.84 MCNY-21.71%
31.72 MCNY-261.01%
-19.70 MCNY-40.85%
-33.31 MCNY-221.14%
27.50 MCNY-242.03%
-19.36 MCNY-7.58%
-20.95 MCNY—
Access this data via the Eulerpool API
Get Free API Key

Landfar Bio medicine Co Stock analysis

What does Landfar Bio medicine Co do? Landfar Bio medicine Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Landfar Bio medicine Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Landfar Bio medicine Co is 30.86 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Landfar Bio medicine Co changed from -12.32 M CNY to 30.86 M CNY, representing a -350.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Landfar Bio medicine Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Landfar Bio medicine Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Landfar Bio medicine Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Landfar Bio medicine Co